101
|
Maekawa F, Oyama Y, Konno C, Wada M, Ikeda Y. Measurement of Gamma-Ray Spectra and Heating Rates in Iron and Stainless Steel Shields Bombarded by Deuterium-Tritium Neutrons and Validation of Secondary-Gamma-Ray Data in Evaluated Nuclear Data Libraries. NUCL SCI ENG 2017. [DOI: 10.13182/nse97-a24472] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
102
|
Ikeda Y, Konno C, Maekawa H. Measurement of Radioactivity Production for48V56Co, and65Zn Via the (p,n) Sequential Reaction Processes in Titanium, Iron, and Copper Metals Associated with 14-MeV Neutron Irradiation. NUCL SCI ENG 2017. [DOI: 10.13182/nse94-a21477] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
103
|
Ikeda Y, Cheng ET, Konno C, Maekawa H. Measurement of Neutron Activation Cross Sections for the99Tc(n,p)99Mo,99Tc(n,α)96Nb,99Tc(n,n′α)95Nb, and99Tc(n,n′)99mTc Reactions at 13.5 and 14.8 MeV. NUCL SCI ENG 2017. [DOI: 10.13182/nse94-a21478] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
104
|
Kamada Y, Fujita T, Ishida S, Kikuchi M, Ide S, Takizuka T, Shirai H, Koide Y, Fukuda T, Hosogane N, Tsuchiya K, Hatae T, Takenaga H, Sato M, Nakamura H, Naito O, Asakura N, Kubo H, Higashijima S, Miura Y, Yoshino R, Shimizu K, Ozeki T, Hirayama T, Mori M, Sakamoto Y, Kawano Y, Isayama A, Ushigusa K, Ikeda Y, Kimura H, Fujii T, Imai T, Nagami M, Takeji S, Oikawa T, Suzuki T, Nakano T, Oyama N, Sakurai S, Konoshima S, Sugie T, Tobita K, Kondoh T, Tamai H, Neyatani Y, Sakasai A, Kusama Y, Itami K, Shimada M, Ninomiya H, Urano H. Fusion Plasma Performance and Confinement Studies on JT-60 and JT-60U. FUSION SCIENCE AND TECHNOLOGY 2017. [DOI: 10.13182/fst02-a227] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
105
|
Akino N, Ebisawa N, Honda A, Ikeda Y, Kawai M, Kazawa M, Mogaki K, Ohga T, Umeda N, Usui K, Yamamoto T, Grisham L. Long Pulse Operation on NBI Systems for JT-60U. FUSION SCIENCE AND TECHNOLOGY 2017. [DOI: 10.13182/fst05-a777] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
106
|
Ikeda Y, Kasugai A, Moriyama S, Kajiwara K, Seki M, Tsuneoka M, Takahashi K, Anno K, Hamamatsu K, Hiranai S, Ikeda Y, Imai T, Sakamoto K, Shimono M, Shinozaki S, Terakado M, Yamamoto T, Yokokura K, Fujii T. The 110-GHz Electron Cyclotron Range of Frequency System on JT-60U: Design and Operation. FUSION SCIENCE AND TECHNOLOGY 2017. [DOI: 10.13182/fst02-a239] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
107
|
Seki M, Ikeda Y, Maebara S, Moriyama S, Naito O, Anno K, Hiranai S, Shimono M, Shinozaki S, Terakado M, Yokokura K, Yamamoto T, Fujii T. Development and Operation of the Lower Hybrid Range of Frequency System on JT-60U. FUSION SCIENCE AND TECHNOLOGY 2017. [DOI: 10.13182/fst02-a240] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
108
|
Ushigusa K, Ide S, Oikawa T, Suzuki T, Kamada Y, Fujita T, Ikeda Y, Naito O, Matsuoka M, Kondoh T, Isayama A, Seki M, Imai T, Sakamoto K, Umeda N, Hamamatsu K, Fujii T, Uehara K, Yamamoto T, Miura Y, Kikuchi M, Kuriyama M, Ninomiy H. Noninductive Current Drive and Steady-State Operation in JT-60U. FUSION SCIENCE AND TECHNOLOGY 2017. [DOI: 10.13182/fst02-a228] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
109
|
Ikeda Y, Zabbarova I, Schaefer CM, Bushnell D, De Groat WC, Kanai A, Bates CM. Fgfr2 is integral for bladder mesenchyme patterning and function. Am J Physiol Renal Physiol 2017; 312:F607-F618. [PMID: 28052872 DOI: 10.1152/ajprenal.00463.2016] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2016] [Revised: 12/19/2016] [Accepted: 12/28/2016] [Indexed: 11/22/2022] Open
Abstract
While urothelial signals, including sonic hedgehog (Shh), drive bladder mesenchyme differentiation, it is unclear which pathways within the mesenchyme are critical for its development. Studies have shown that fibroblast growth factor receptor 2 (Fgfr2) is necessary for kidney and ureter mesenchymal development. Our objective was to determine the role of Fgfr2 in bladder mesenchyme. We used Tbx18cre mice to delete Fgfr2 in bladder mesenchyme (Fgfr2BM-/-). We performed three-dimensional reconstructions, quantitative real-time PCR, in situ hybridization, immunolabeling, ELISAs, immunoblotting, void stain on paper, ex vivo bladder sheet assays, and in vivo decerebrated cystometry. Compared with controls, embryonic (E) day 16.5 (E16.5) Fgfr2BM-/- bladders have thin muscle layers with reduced α-smooth muscle actin levels and thickened lamina propria with increased collagen expression that intrudes into muscle. From postnatal (P) day 1 (P1) to P30, Fgfr2BM-/- bladders demonstrate progressive muscle loss and increased collagen expression. Postnatal Fgfr2BM-/- bladder sheets exhibit decreased contractility and increased passive stretch tension compared with controls. In vivo cystometry revealed high baseline and threshold pressures and shortened intercontractile intervals in Fgfr2BM-/- bladders compared with controls. Mechanistically, while Shh expression appears normal, mRNA and protein readouts of hedgehog activity are increased in E16.5 Fgfr2BM-/- bladders compared with controls. Moreover, E16.5Fgfr2BM-/- bladders exhibit higher levels of Cdo and Boc, hedgehog coreceptors that enhance sensitivity to Shh, than controls. Fgfr2 is critical for bladder mesenchyme patterning by virtue of its role in modulation of hedgehog signaling.
Collapse
|
110
|
Nara R, Ikeda Y, Ichikawa H, Sato D, Shimojo H, Baba Y, Shimoyama Y. The relationship between the performance of backstroke start and medicine ball backward throwing. J Sci Med Sport 2017. [DOI: 10.1016/j.jsams.2017.01.152] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
111
|
Junkong P, Cornish K, Ikeda Y. Characteristics of mechanical properties of sulphur cross-linked guayule and dandelion natural rubbers. RSC Adv 2017. [DOI: 10.1039/c7ra08554k] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
Abstract
Roles of non-rubber components in guayule and dandelion natural rubbers on the mechanical properties are firstly revealed by analysing the Mullins effect, dynamic mechanical properties and strain-induced crystallization from a new viewpoint.
Collapse
|
112
|
Adare A, Aidala C, Ajitanand N, Akiba Y, Akimoto R, Alfred M, Apadula N, Aramaki Y, Asano H, Atomssa E, Awes T, Azmoun B, Babintsev V, Bai M, Bandara N, Bannier B, Barish K, Bathe S, Bazilevsky A, Beaumier M, Beckman S, Belmont R, Berdnikov A, Berdnikov Y, Black D, Blau D, Bok J, Boyle K, Brooks M, Bryslawskyj J, Buesching H, Bumazhnov V, Campbell S, Chen CH, Chi C, Chiu M, Choi I, Choi J, Chujo T, Citron Z, Csanád M, Csörgő T, Danley T, Datta A, Daugherity M, David G, DeBlasio K, Dehmelt K, Denisov A, Deshpande A, Desmond E, Ding L, Dion A, Diss P, Do J, Drees A, Drees K, Durham J, Durum A, Enokizono A, En’yo H, Esumi S, Fadem B, Feege N, Fields D, Finger M, Finger M, Fokin S, Frantz J, Franz A, Frawley A, Gal C, Gallus P, Garg P, Ge H, Giordano F, Glenn A, Goto Y, Grau N, Greene S, Grosse Perdekamp M, Gu Y, Gunji T, Guragain H, Hachiya T, Haggerty J, Hahn K, Hamagaki H, Hamilton H, Han S, Hanks J, Hasegawa S, Haseler T, Hashimoto K, He X, Hemmick T, Hill J, Hollis R, Homma K, Hong B, Hoshino T, Hotvedt N, Huang J, Huang S, Ikeda Y, Imai K, Imazu Y, Inaba M, Iordanova A, Isenhower D, Ivanishchev D, Jacak B, Jeon S, Jezghani M, Jia J, Jiang X, Johnson B, Joo E, Joo K, Jouan D, Jumper D, Kanda S, Kang J, Kang J, Kawall D, Kazantsev A, Key J, Khachatryan V, Khanzadeev A, Kihara K, Kim C, Kim D, Kim D, Kim EJ, Kim G, Kim HJ, Kim M, Kim Y, Kimelman B, Kistenev E, Kitamura R, Klatsky J, Kleinjan D, Kline P, Koblesky T, Kofarago M, Komkov B, Koster J, Kotov D, Kurita K, Kurosawa M, Kwon Y, Lacey R, Lajoie J, Lebedev A, Lee K, Lee S, Lee S, Leitch M, Leitgab M, Li X, Lim S, Liu M, Lynch D, Makdisi Y, Makek M, Manion A, Manko V, Mannel E, McCumber M, McGaughey P, McGlinchey D, McKinney C, Meles A, Mendoza M, Meredith B, Miake Y, Mignerey A, Miller A, Milov A, Mishra D, Mitchell J, Miyasaka S, Mizuno S, Mohanty A, Montuenga P, Moon T, Morrison D, Moukhanova T, Murakami T, Murata J, Mwai A, Nagamiya S, Nagashima K, Nagle J, Nagy M, Nakagawa I, Nakagomi H, Nakano K, Nattrass C, Netrakanti P, Nihashi M, Niida T, Nishimura S, Nouicer R, Novák T, Novitzky N, Nyanin A, O’Brien E, Ogilvie C, Orjuela Koop J, Osborn J, Oskarsson A, Ozawa K, Pak R, Pantuev V, Papavassiliou V, Park J, Park S, Pate S, Patel L, Patel M, Peng JC, Perepelitsa D, Perera G, Peressounko D, Perry J, Petti R, Pinkenburg C, Pinson R, Pisani R, Purschke M, Rak J, Ramson B, Ravinovich I, Read K, Reynolds D, Riabov V, Riabov Y, Rinn T, Riveli N, Roach D, Rolnick S, Rosati M, Rowan Z, Rubin J, Sahlmueller B, Saito N, Sakaguchi T, Sako H, Samsonov V, Sarsour M, Sato S, Sawada S, Schaefer B, Schmoll B, Sedgwick K, Seele J, Seidl R, Sen A, Seto R, Sett P, Sexton A, Sharma D, Shein I, Shibata TA, Shigaki K, Shimomura M, Shukla P, Sickles A, Silva C, Silvermyr D, Singh B, Singh C, Singh V, Slunečka M, Snowball M, Soltz R, Sondheim W, Sorensen S, Sourikova I, Stankus P, Stepanov M, Stoll S, Sugitate T, Sukhanov A, Sumita T, Sun J, Sziklai J, Takahara A, Taketani A, Tanida K, Tannenbaum M, Tarafdar S, Taranenko A, Tieulent R, Timilsina A, Todoroki T, Tomášek M, Torii H, Towell C, Towell M, Towell R, Towell R, Tserruya I, van Hecke H, Vargyas M, Velkovska J, Virius M, Vrba V, Vznuzdaev E, Wang X, Watanabe D, Watanabe Y, Watanabe Y, Wei F, Whitaker S, White A, Wolin S, Woody C, Wysocki M, Xia B, Xue L, Yalcin S, Yamaguchi Y, Yanovich A, Yoo J, Yoon I, Younus I, Yu H, Yushmanov I, Zajc W, Zelenski A, Zhou S, Zou L. Measurements of double-helicity asymmetries in inclusive
J/ψ
production in longitudinally polarized
p+p
collisions at
s=510
GeV. Int J Clin Exp Med 2016. [DOI: 10.1103/physrevd.94.112008] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
113
|
Otsubo H, Akatsuka Y, Takashima H, Suzuki T, Suzuki D, Kamiya T, Ikeda Y, Matsumura T, Yamashita T, Shino K. MRI depiction and 3D visualization of three anterior cruciate ligament bundles. Clin Anat 2016; 30:276-283. [DOI: 10.1002/ca.22810] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2016] [Revised: 11/14/2016] [Accepted: 11/14/2016] [Indexed: 11/07/2022]
|
114
|
Nemoto MW, Ikeda Y, Ii N, Toita T, Togasaki G, Kanazawa A, Kurokawa M, Harada R, Kobayashi H, Matsumoto K, Masuda Y, Uno T. Multi-Institutional Comparative Study of MRI Technique in Cervical Cancer Image-Based Brachytherapy (IGBT): 3D MRI With High Sampling Efficiency Versus Conventional 2D Multiplanar MRI. Int J Radiat Oncol Biol Phys 2016. [DOI: 10.1016/j.ijrobp.2016.06.1389] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
115
|
Miyakawa Y, Katsutani S, Yano T, Nomura S, Nishiwaki K, Tomiyama Y, Higashihara M, Shirasugi Y, Nishikawa M, Ozaki K, Abe T, Kikuchi K, Kanakura Y, Fujimura K, Ikeda Y, Okamoto S. Efficacy and safety of rituximab in Japanese patients with relapsed chronic immune thrombocytopenia refractory to conventional therapy. Int J Hematol 2016; 102:654-61. [PMID: 26466831 DOI: 10.1007/s12185-015-1887-9] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2015] [Revised: 10/06/2015] [Accepted: 10/06/2015] [Indexed: 11/25/2022]
Abstract
Primary immune thrombocytopenia (ITP) is an autoimmune disease mediated by the production of autoantibody against platelets. Rituximab, an anti-CD20 antibody, is reported to be useful for treatment of ITP. In Japan, however, robust evidence on this treatment has not been accumulated. Hence, we conducted this open-label phase III clinical trial to confirm the efficacy and safety of rituximab, administered at 375 mg/m² once per week at weekly intervals for 4 consecutive weeks in Japanese patients with chronic ITP, who had relapsed and were refractory to conventional therapy. The primary endpoint was defined as the percentage of patients with a platelet count above 50 × 10⁹/L at week 24 after the first dose of rituximab, which was 30.8% of 26 patients (95% confidence interval 14.3-51.8%). Although the lower confidence limit of primary endpoint failed to meet the pre-specified threshold of 20%, the clinical efficacy of rituximab is substantial in consideration of the 2% response rate in the placebo arm in other clinical studies in patients with chronic ITP. We conclude that rituximab is clinically useful and safe in the treatment of Japanese patients with chronic ITP, achieving the goal of maintaining platelet count and reducing risk of bleeding while minimizing treatment-related toxicity.
Collapse
|
116
|
Abtan J, Bhatt DL, Elbez Y, Sorbets E, Eagle K, Ikeda Y, Wu D, Hanson ME, Hannachi H, Singhal PK, Steg PG, Ducrocq G. Residual Ischemic Risk and Its Determinants in Patients With Previous Myocardial Infarction and Without Prior Stroke or TIA: Insights From the REACH Registry. Clin Cardiol 2016; 39:670-677. [PMID: 27588731 DOI: 10.1002/clc.22583] [Citation(s) in RCA: 35] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/22/2016] [Revised: 07/05/2016] [Accepted: 07/12/2016] [Indexed: 01/14/2023] Open
Abstract
BACKGROUND Although the rate of in-hospital ischemic events after myocardial infarction (MI) has dramatically decreased, long-term residual risk may remain substantial. However, most of the information on current residual risk is derived from highly selected randomized trials. HYPOTHESIS In patients with previous MI and no prior ischemic stroke/transient ischemic attack (TIA), residual ischemic risk increases over time. METHODS Using the international Reduction of Atherothrombosis for Continued Health (REACH) registry, we analyzed baseline characteristics and 4-year follow-up of patients with previous MI and no history of stroke/TIA to describe annual rates of recurrent ischemic events globally and by geography. The primary outcome was the composite of cardiovascular death, MI, or stroke. Multivariate analysis identified risk factors associated with recurrent ischemic events. RESULTS Data from 16 770 patients enrolled at 5587 sites in 44 countries were analyzed. The rate of the primary outcome increased annually from 4.7% during year 1 to reach a 4-year rate of 15.1%. Compared with North America, Japan experienced lower ischemic event rates (P < 0.01), whereas Eastern Europe (P < 0.01) and the Middle East (P = 0.01) experienced higher ischemic event rates. The presence of congestive heart failure, polyvascular disease, diabetes, atrial fibrillation or flutter, and older age were associated with increased residual risk (all P < 0.01). Statin use was associated with lower ischemic risk (P < 0.01). CONCLUSIONS In this study, residual ischemic risk after MI accrued progressively up to 4 years of follow-up, emphasizing the value of intensive secondary prevention strategies to minimize residual risk.
Collapse
|
117
|
Ogawa H, Isshiki T, Kimura T, Yokoi H, Nanto S, Takayama M, Kitagawa K, Nishikawa M, Miyazaki S, Ikeda Y, Nakamura M, Tanaka Y, Saito S. Effects of CYP2C19 allelic variants on inhibition of platelet aggregation and major adverse cardiovascular events in Japanese patients with acute coronary syndrome: The PRASFIT-ACS study. J Cardiol 2016; 68:29-36. [DOI: 10.1016/j.jjcc.2015.07.019] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/30/2015] [Revised: 07/07/2015] [Accepted: 07/22/2015] [Indexed: 01/06/2023]
|
118
|
Ono-Uruga Y, Tozawa K, Horiuchi T, Murata M, Okamoto S, Ikeda Y, Suda T, Matsubara Y. Human adipose tissue-derived stromal cells can differentiate into megakaryocytes and platelets by secreting endogenous thrombopoietin. J Thromb Haemost 2016; 14:1285-97. [PMID: 26990635 DOI: 10.1111/jth.13313] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2015] [Indexed: 12/13/2022]
Abstract
UNLABELLED Essentials Manufacturing platelets from a donor-independent source is highlighted in transfusion medicine. We examined the differentiation of adipose tissue-derived stromal cells (ASCs) into platelets. Endogenous thrombopoietin (TPO) induced ASCs differentiation into megakaryocytes and platelets. TPO secretion from ASCs was due to an interaction of transferrin with its receptor CD71. SUMMARY Background Ex vivo production of megakaryocytes (MKs) and platelets from a donor-independent source is currently of intense interest in transfusion medicine. Adipose tissue-derived stromal cells (ASCs) constitute an attractive candidate cell source, because inducing these cells into MK lineages requires no gene transfer and only endogenous transcription factors containing p45NF-E2/Maf, an MK-inducing factor. Objectives To examine whether ASCs differentiate into MK lineages by using endogenous thrombopoietin (TPO), a primary cytokine that drives MK lineages. Methods TPO levels were measured by quantitative real-time PCR and ELISA. To investigate the effects of endogenous TPO on MK and platelet production, surface marker expression and functions for platelets were analyzed in ASC-derived cells cultured in the presence or absence of recombinant TPO. Based on a screening test, the role of transferrin receptor CD71 in TPO production and MK differentiation was examined with anti-CD71 antibody, small interfering RNA (siRNA) against CD71 (siRNA-CD71), and CD71-positive/negative cells. Results ASCs secreted TPO during MK differentiation, and the endogenous TPO facilitated MK and platelet production from ASCs. TPO secretion from ASCs occurred in a transferrin-dependent manner. ASCs treated with anti-CD71 antibody or transfected with siRNA-CD71 produced markedly less TPO. The TPO levels and MK yield were significantly higher when CD71-positive ASCs were used than when CD71-negative ASCs were used. Conclusions CD71 might be an appropriate marker for MK progenitor cells among human ASCs, because of the higher capacity of CD71-positive cells to produce TPO and their ability to differentiate into MKs. These findings could help to establish an efficient method for platelet production.
Collapse
|
119
|
Uchiyama S, Ishizuka N, Shimada K, Teramoto T, Yamazaki T, Oikawa S, Sugawara M, Ando K, Murata M, Yokoyama K, Minematsu K, Matsumoto M, Ikeda Y. Aspirin for Stroke Prevention in Elderly Patients With Vascular Risk Factors: Japanese Primary Prevention Project. Stroke 2016; 47:1605-11. [PMID: 27165949 DOI: 10.1161/strokeaha.115.012461] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2015] [Accepted: 03/29/2016] [Indexed: 11/16/2022]
Abstract
BACKGROUND AND PURPOSE The effect of aspirin in primary prevention of stroke is controversial among clinical trials conducted in Western countries, and no data are available for Asian populations with a high risk of intracranial hemorrhage. The objective of this study was to evaluate the effect of aspirin on the risk of stroke and intracranial hemorrhage in the Japanese Primary Prevention Project (JPPP). METHODS A total of 14 464 patients (age, 60-85 years) with hypertension, dyslipidemia, and diabetes mellitus participated and were randomized into 2 treatment groups: 100 mg of aspirin or no aspirin. The median follow-up period was 5.02 years. RESULTS The cumulative rate of fatal or nonfatal stroke was similar for the aspirin (2.068%; 95% confidence interval [CI], 1.750-2.443) and no aspirin (2.299%; 95% CI, 1.963-2.692) groups at 5 years; the estimated hazard ratio was 0.927 (95% CI, 0.741-1.160; P=0.509). Aspirin nonsignificantly reduced the risk of ischemic stroke or transient ischemic attack (hazard ratio, 0.783; 95% CI, 0.606-1.012; P=0.061) and nonsignificantly increased the risk of intracranial hemorrhage (hazard ratio, 1.463; 95% CI; 0.956-2.237; P=0.078). A Cox regression adjusted by the risk factors for all stroke, which were age >70 years, smoking, and diabetes mellitus, supported the above result. CONCLUSIONS Aspirin did not show any net benefit for the primary prevention of stroke in elderly Japanese patients with risk factors for stroke, whereas age >70 years, smoking, and diabetes mellitus were risk factors for stroke regardless of aspirin treatment. CLINICAL TRIAL REGISTRATION URL: http://www.clinicaltrials.gov. Unique identifier: NCT00225849.
Collapse
|
120
|
Matsuo K, Takazawa Y, Ross MS, Elishaev E, Podzielinski I, Yunokawa M, Sheridan TB, Bush SH, Klobocista MM, Blake EA, Takano T, Matsuzaki S, Baba T, Satoh S, Shida M, Nishikawa T, Ikeda Y, Adachi S, Yokoyama T, Takekuma M, Fujiwara K, Hazama Y, Kadogami D, Moffitt MN, Takeuchi S, Nishimura M, Iwasaki K, Ushioda N, Johnson MS, Yoshida M, Hakam A, Li SW, Richmond AM, Machida H, Mhawech-Fauceglia P, Ueda Y, Yoshino K, Yamaguchi K, Oishi T, Kajiwara H, Hasegawa K, Yasuda M, Kawana K, Suda K, Miyake TM, Moriya T, Yuba Y, Morgan T, Fukagawa T, Wakatsuki A, Sugiyama T, Pejovic T, Nagano T, Shimoya K, Andoh M, Shiki Y, Enomoto T, Sasaki T, Fujiwara K, Mikami M, Shimada M, Konishi I, Kimura T, Post MD, Shahzad MM, Im DD, Yoshida H, Omatsu K, Ueland FR, Kelley JL, Karabakhtsian RG, Roman LD. Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma. Ann Oncol 2016; 27:1257-66. [PMID: 27052653 DOI: 10.1093/annonc/mdw161] [Citation(s) in RCA: 51] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2015] [Accepted: 03/29/2016] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND To examine the effect of the histology of carcinoma and sarcoma components on survival outcome of uterine carcinosarcoma. PATIENTS AND METHODS A multicenter retrospective study was conducted to examine uterine carcinosarcoma cases that underwent primary surgical staging. Archived slides were examined and histologic patterns were grouped based on carcinoma (low-grade versus high-grade) and sarcoma (homologous versus heterologous) components, correlating to clinico-pathological demographics and outcomes. RESULTS Among 1192 cases identified, 906 cases were evaluated for histologic patterns (carcinoma/sarcoma) with high-grade/homologous (40.8%) being the most common type followed by high-grade/heterologous (30.9%), low-grade/homologous (18.0%), and low-grade/heterologous (10.3%). On multivariate analysis, high-grade/heterologous (5-year rate, 34.0%, P = 0.024) and high-grade/homologous (45.8%, P = 0.017) but not low-grade/heterologous (50.6%, P = 0.089) were independently associated with decreased progression-free survival (PFS) compared with low-grade/homologous (60.3%). In addition, older age, residual disease at surgery, large tumor, sarcoma dominance, deep myometrial invasion, lymphovascular space invasion, and advanced-stage disease were independently associated with decreased PFS (all, P < 0.01). Both postoperative chemotherapy (5-year rates, 48.6% versus 39.0%, P < 0.001) and radiotherapy (50.1% versus 44.1%, P = 0.007) were significantly associated with improved PFS in univariate analysis. However, on multivariate analysis, only postoperative chemotherapy remained an independent predictor for improved PFS [hazard ratio (HR) 0.34, 95% confidence interval (CI) 0.27-0.43, P < 0.001]. On univariate analysis, significant treatment benefits for PFS were seen with ifosfamide for low-grade carcinoma (82.0% versus 49.8%, P = 0.001), platinum for high-grade carcinoma (46.9% versus 32.4%, P = 0.034) and homologous sarcoma (53.1% versus 38.2%, P = 0.017), and anthracycline for heterologous sarcoma (66.2% versus 39.3%, P = 0.005). Conversely, platinum, taxane, and anthracycline for low-grade carcinoma, and anthracycline for homologous sarcoma had no effect on PFS compared with non-chemotherapy group (all, P > 0.05). On multivariate analysis, ifosfamide for low-grade/homologous (HR 0.21, 95% CI 0.07-0.63, P = 0.005), platinum for high-grade/homologous (HR 0.36, 95% CI 0.22-0.60, P < 0.001), and anthracycline for high-grade/heterologous (HR 0.30, 95% CI 0.14-0.62, P = 0.001) remained independent predictors for improved PFS. Analyses of 1096 metastatic sites showed that carcinoma components tended to spread lymphatically, while sarcoma components tended to spread loco-regionally (P < 0.001). CONCLUSION Characterization of histologic pattern provides valuable information in the management of uterine carcinosarcoma.
Collapse
|
121
|
Adare A, Aidala C, Ajitanand NN, Akiba Y, Al-Bataineh H, Alexander J, Alfred M, Angerami A, Aoki K, Apadula N, Aramaki Y, Asano H, Atomssa ET, Averbeck R, Awes TC, Azmoun B, Babintsev V, Bai M, Baksay G, Baksay L, Bandara NS, Bannier B, Barish KN, Bassalleck B, Basye AT, Bathe S, Baublis V, Baumann C, Bazilevsky A, Beaumier M, Beckman S, Belikov S, Belmont R, Bennett R, Berdnikov A, Berdnikov Y, Bhom JH, Blau DS, Bok JS, Boyle K, Brooks ML, Bryslawskyj J, Buesching H, Bumazhnov V, Bunce G, Butsyk S, Campbell S, Caringi A, Chen CH, Chi CY, Chiu M, Choi IJ, Choi JB, Choudhury RK, Christiansen P, Chujo T, Chung P, Chvala O, Cianciolo V, Citron Z, Cole BA, Conesa Del Valle Z, Connors M, Csanád M, Csörgő T, Dahms T, Dairaku S, Danchev I, Danley TW, Das K, Datta A, Daugherity MS, David G, Dayananda MK, DeBlasio K, Dehmelt K, Denisov A, Deshpande A, Desmond EJ, Dharmawardane KV, Dietzsch O, Dion A, Diss PB, Do JH, Donadelli M, D'Orazio L, Drapier O, Drees A, Drees KA, Durham JM, Durum A, Dutta D, Edwards S, Efremenko YV, Ellinghaus F, Engelmore T, Enokizono A, En'yo H, Esumi S, Fadem B, Feege N, Fields DE, Finger M, Finger M, Fleuret F, Fokin SL, Fraenkel Z, Frantz JE, Franz A, Frawley AD, Fujiwara K, Fukao Y, Fusayasu T, Gal C, Gallus P, Garg P, Garishvili I, Ge H, Giordano F, Glenn A, Gong H, Gonin M, Goto Y, Granier de Cassagnac R, Grau N, Greene SV, Grim G, Grosse Perdekamp M, Gunji T, Gustafsson HÅ, Hachiya T, Haggerty JS, Hahn KI, Hamagaki H, Hamblen J, Hamilton HF, Han R, Han SY, Hanks J, Hasegawa S, Haseler TOS, Hashimoto K, Haslum E, Hayano R, He X, Heffner M, Hemmick TK, Hester T, Hill JC, Hohlmann M, Hollis RS, Holzmann W, Homma K, Hong B, Horaguchi T, Hornback D, Hoshino T, Hotvedt N, Huang J, Huang S, Ichihara T, Ichimiya R, Ikeda Y, Imai K, Inaba M, Iordanova A, Isenhower D, Ishihara M, Issah M, Ivanishchev D, Iwanaga Y, Jacak BV, Jezghani M, Jia J, Jiang X, Jin J, Johnson BM, Jones T, Joo KS, Jouan D, Jumper DS, Kajihara F, Kamin J, Kanda S, Kang JH, Kapustinsky J, Karatsu K, Kasai M, Kawall D, Kawashima M, Kazantsev AV, Kempel T, Key JA, Khachatryan V, Khanzadeev A, Kijima KM, Kikuchi J, Kim A, Kim BI, Kim C, Kim DJ, Kim EJ, Kim GW, Kim M, Kim YJ, Kimelman B, Kinney E, Kiss Á, Kistenev E, Kitamura R, Klatsky J, Kleinjan D, Kline P, Koblesky T, Kochenda L, Komkov B, Konno M, Koster J, Kotov D, Král A, Kravitz A, Kunde GJ, Kurita K, Kurosawa M, Kwon Y, Kyle GS, Lacey R, Lai YS, Lajoie JG, Lebedev A, Lee DM, Lee J, Lee KB, Lee KS, Lee S, Lee SH, Leitch MJ, Leite MAL, Li X, Lichtenwalner P, Liebing P, Lim SH, Linden Levy LA, Liška T, Liu H, Liu MX, Love B, Lynch D, Maguire CF, Makdisi YI, Makek M, Malik MD, Manion A, Manko VI, Mannel E, Mao Y, Masui H, Matathias F, McCumber M, McGaughey PL, McGlinchey D, McKinney C, Means N, Meles A, Mendoza M, Meredith B, Miake Y, Mibe T, Mignerey AC, Miki K, Milov A, Mishra DK, Mitchell JT, Miyasaka S, Mizuno S, Mohanty AK, Montuenga P, Moon HJ, Moon T, Morino Y, Morreale A, Morrison DP, Moukhanova TV, Murakami T, Murata J, Mwai A, Nagamiya S, Nagashima K, Nagle JL, Naglis M, Nagy MI, Nakagawa I, Nakagomi H, Nakamiya Y, Nakamura KR, Nakamura T, Nakano K, Nam S, Nattrass C, Netrakanti PK, Newby J, Nguyen M, Nihashi M, Niida T, Nishimura S, Nouicer R, Novák T, Novitzky N, Nyanin AS, Oakley C, O'Brien E, Oda SX, Ogilvie CA, Oka M, Okada K, Onuki Y, Orjuela Koop JD, Osborn JD, Oskarsson A, Ouchida M, Ozawa K, Pak R, Pantuev V, Papavassiliou V, Park IH, Park JS, Park S, Park SK, Park WJ, Pate SF, Patel M, Pei H, Peng JC, Pereira H, Perepelitsa DV, Perera GDN, Peressounko DY, Perry J, Petti R, Pinkenburg C, Pinson R, Pisani RP, Proissl M, Purschke ML, Qu H, Rak J, Ramson BJ, Ravinovich I, Read KF, Rembeczki S, Reygers K, Reynolds D, Riabov V, Riabov Y, Richardson E, Rinn T, Roach D, Roche G, Rolnick SD, Rosati M, Rosen CA, Rosendahl SSE, Rowan Z, Rubin JG, Ružička P, Sahlmueller B, Saito N, Sakaguchi T, Sakashita K, Sako H, Samsonov V, Sano S, Sarsour M, Sato S, Sato T, Sawada S, Schaefer B, Schmoll BK, Sedgwick K, Seele J, Seidl R, Sen A, Seto R, Sett P, Sexton A, Sharma D, Shein I, Shibata TA, Shigaki K, Shimomura M, Shoji K, Shukla P, Sickles A, Silva CL, Silvermyr D, Silvestre C, Sim KS, Singh BK, Singh CP, Singh V, Slunečka M, Snowball M, Soltz RA, Sondheim WE, Sorensen SP, Sourikova IV, Stankus PW, Stenlund E, Stepanov M, Stoll SP, Sugitate T, Sukhanov A, Sumita T, Sun J, Sziklai J, Takagui EM, Taketani A, Tanabe R, Tanaka Y, Taneja S, Tanida K, Tannenbaum MJ, Tarafdar S, Taranenko A, Themann H, Thomas D, Thomas TL, Tieulent R, Timilsina A, Todoroki T, Togawa M, Toia A, Tomášek L, Tomášek M, Torii H, Towell CL, Towell R, Towell RS, Tserruya I, Tsuchimoto Y, Vale C, Valle H, van Hecke HW, Vazquez-Zambrano E, Veicht A, Velkovska J, Vértesi R, Virius M, Vrba V, Vznuzdaev E, Wang XR, Watanabe D, Watanabe K, Watanabe Y, Watanabe YS, Wei F, Wei R, Wessels J, White AS, White SN, Winter D, Woody CL, Wright RM, Wysocki M, Xia B, Xue L, Yalcin S, Yamaguchi YL, Yamaura K, Yang R, Yanovich A, Ying J, Yokkaichi S, Yoo JH, Yoon I, You Z, Young GR, Younus I, Yu H, Yushmanov IE, Zajc WA, Zelenski A, Zhou S, Zou L. Centrality-Dependent Modification of Jet-Production Rates in Deuteron-Gold Collisions at √[s(NN)]=200 GeV. PHYSICAL REVIEW LETTERS 2016; 116:122301. [PMID: 27058071 DOI: 10.1103/physrevlett.116.122301] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/05/2015] [Indexed: 06/05/2023]
Abstract
Jet production rates are measured in p+p and d+Au collisions at sqrt[s_{NN}]=200 GeV recorded in 2008 with the PHENIX detector at the Relativistic Heavy Ion Collider. Jets are reconstructed using the R=0.3 anti-k_{t} algorithm from energy deposits in the electromagnetic calorimeter and charged tracks in multiwire proportional chambers, and the jet transverse momentum (p_{T}) spectra are corrected for the detector response. Spectra are reported for jets with 12<p_{T}<50 GeV/c, within a pseudorapidity acceptance of |η|<0.3. The nuclear-modification factor (R_{dAu}) values for 0%-100% d+Au events are found to be consistent with unity, constraining the role of initial state effects on jet production. However, the centrality-selected R_{dAu} values and central-to-peripheral ratios (R_{CP}) show large, p_{T}-dependent deviations from unity, challenging the conventional models that relate hard-process rates and soft-particle production in collisions involving nuclei.
Collapse
|
122
|
Okumura Y, Gobin R, Knaster J, Heidinger R, Ayala JM, Bolzon B, Cara P, Chauvin N, Chel S, Gex D, Harrault F, Ichimiya R, Ihara A, Ikeda Y, Kasugai A, Kikuchi T, Kitano T, Komata M, Kondo K, Maebara S, Marqueta A, O'Hira S, Perez M, Phillips G, Pruneri G, Sakamoto K, Scantamburlo F, Senée F, Shinto K, Sugimoto M, Takahashi H, Usami H, Valette M. Operation and commissioning of IFMIF (International Fusion Materials Irradiation Facility) LIPAc injector. THE REVIEW OF SCIENTIFIC INSTRUMENTS 2016; 87:02A739. [PMID: 26931957 DOI: 10.1063/1.4936248] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
The objective of linear IFMIF prototype accelerator is to demonstrate 125 mA/CW deuterium ion beam acceleration up to 9 MeV. The injector has been developed in CEA Saclay and already demonstrated 140 mA/100 keV deuterium beam [R. Gobin et al., Rev. Sci. Instrum. 85, 02A918 (2014)]. The injector was disassembled and delivered to the International Fusion Energy Research Center in Rokkasho, Japan. After reassembling the injector, commissioning has started in 2014. Up to now, 100 keV/120 mA/CW hydrogen and 100 keV/90 mA/CW deuterium ion beams have been produced stably from a 10 mm diameter extraction aperture with a low beam emittance of 0.21 π mm mrad (rms, normalized). Neutron production by D-D reaction up to 2.4 × 10(9) n/s has been observed in the deuterium operation.
Collapse
|
123
|
Shinto K, Senée F, Ayala JM, Bolzon B, Chauvin N, Gobin R, Ichimiya R, Ihara A, Ikeda Y, Kasugai A, Kitano T, Kondo K, Marqueta A, Okumura Y, Takahashi H, Valette M. Measurement of ion species in high current ECR H⁺/D⁺ ion source for IFMIF (International Fusion Materials Irradiation Facility). THE REVIEW OF SCIENTIFIC INSTRUMENTS 2016; 87:02A727. [PMID: 26931945 DOI: 10.1063/1.4933342] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
Ion species ratio of high current positive hydrogen/deuterium ion beams extracted from an electron-cyclotron-resonance ion source for International Fusion Materials Irradiation Facility accelerator was measured by the Doppler shift Balmer-α line spectroscopy. The proton (H(+)) ratio at the middle of the low energy beam transport reached 80% at the hydrogen ion beam extraction of 100 keV/160 mA and the deuteron (D(+)) ratio reached 75% at the deuterium ion beam extraction of 100 keV/113 mA. It is found that the H(+) ratio measured by the spectroscopy gives lower than that derived from the phase-space diagram measured by an Allison scanner type emittance monitor. The H(+)/D(+) ratio estimated by the emittance monitor was more than 90% at those extraction currents.
Collapse
|
124
|
Adare A, Aidala C, Ajitanand N, Akiba Y, Akimoto R, Alexander J, Alfred M, Aoki K, Apadula N, Aramaki Y, Asano H, Atomssa E, Awes T, Azmoun B, Babintsev V, Bai M, Bai X, Bandara N, Bannier B, Barish K, Bathe S, Baublis V, Baumann C, Baumgart S, Bazilevsky A, Beaumier M, Beckman S, Belmont R, Berdnikov A, Berdnikov Y, Black D, Blau D, Bok J, Boyle K, Brooks M, Bryslawskyj J, Buesching H, Bumazhnov V, Butsyk S, Campbell S, Chen CH, Chi C, Chiu M, Choi I, Choi J, Choi S, Christiansen P, Chujo T, Cianciolo V, Citron Z, Cole B, Cronin N, Crossette N, Csanád M, Csörgő T, Danley T, Datta A, Daugherity M, David G, DeBlasio K, Dehmelt K, Denisov A, Deshpande A, Desmond E, Ding L, Dion A, Diss P, Do J, D’Orazio L, Drapier O, Drees A, Drees K, Durham J, Durum A, Engelmore T, Enokizono A, En’yo H, Esumi S, Eyser K, Fadem B, Feege N, Fields D, Finger M, Finger M, Fleuret F, Fokin S, Frantz J, Franz A, Frawley A, Fukao Y, Fusayasu T, Gainey K, Gal C, Gallus P, Garg P, Garishvili A, Garishvili I, Ge H, Giordano F, Glenn A, Gong X, Gonin M, Goto Y, Granier de Cassagnac R, Grau N, Greene S, Grosse Perdekamp M, Gu Y, Gunji T, Guragain H, Hachiya T, Haggerty J, Hahn K, Hamagaki H, Hamilton H, Han S, Hanks J, Hasegawa S, Haseler T, Hashimoto K, Hayano R, He X, Hemmick T, Hester T, Hill J, Hollis R, Homma K, Hong B, Hoshino T, Hotvedt N, Huang J, Huang S, Ichihara T, Ikeda Y, Imai K, Imazu Y, Inaba M, Iordanova A, Isenhower D, Isinhue A, Ivanishchev D, Jacak B, Jeon S, Jezghani M, Jia J, Jiang X, Johnson B, Joo E, Joo K, Jouan D, Jumper D, Kamin J, Kanda S, Kang B, Kang J, Kang J, Kapustinsky J, Kawall D, Kazantsev A, Key J, Khachatryan V, Khandai P, Khanzadeev A, Kihara K, Kijima K, Kim C, Kim D, Kim D, Kim EJ, Kim G, Kim HJ, Kim M, Kim YJ, Kim Y, Kimelman B, Kistenev E, Kitamura R, Klatsky J, Kleinjan D, Kline P, Koblesky T, Kofarago M, Komkov B, Koster J, Kotchetkov D, Kotov D, Krizek F, Kurita K, Kurosawa M, Kwon Y, Lacey R, Lai Y, Lajoie J, Lebedev A, Lee D, Lee G, Lee J, Lee K, Lee K, Lee S, Lee S, Leitch M, Leitgab M, Lewis B, Li X, Lim S, Liu M, Lynch D, Maguire C, Makdisi Y, Makek M, Manion A, Manko V, Mannel E, Maruyama T, McCumber M, McGaughey P, McGlinchey D, McKinney C, Meles A, Mendoza M, Meredith B, Miake Y, Mibe T, Mignerey A, Miller A, Milov A, Mishra D, Mitchell J, Miyasaka S, Mizuno S, Mohanty A, Mohapatra S, Montuenga P, Moon T, Morrison D, Moskowitz M, Moukhanova T, Murakami T, Murata J, Mwai A, Nagae T, Nagamiya S, Nagashima K, Nagle J, Nagy M, Nakagawa I, Nakagomi H, Nakamiya Y, Nakamura K, Nakamura T, Nakano K, Nattrass C, Netrakanti P, Nihashi M, Niida T, Nishimura S, Nouicer R, Novák T, Novitzky N, Nyanin A, O’Brien E, Ogilvie C, Oide H, Okada K, Orjuela Koop J, Osborn J, Oskarsson A, Ozaki H, Ozawa K, Pak R, Pantuev V, Papavassiliou V, Park I, Park J, Park S, Park S, Pate S, Patel L, Patel M, Peng JC, Perepelitsa D, Perera G, Peressounko D, Perry J, Petti R, Pinkenburg C, Pinson R, Pisani R, Purschke M, Qu H, Rak J, Ramson B, Ravinovich I, Read K, Reynolds D, Riabov V, Riabov Y, Richardson E, Rinn T, Riveli N, Roach D, Rolnick S, Rosati M, Rowan Z, Rubin J, Ryu M, Sahlmueller B, Saito N, Sakaguchi T, Sako H, Samsonov V, Sarsour M, Sato S, Sawada S, Schaefer B, Schmoll B, Sedgwick K, Seele J, Seidl R, Sekiguchi Y, Sen A, Seto R, Sett P, Sexton A, Sharma D, Shaver A, Shein I, Shibata TA, Shigaki K, Shimomura M, Shoji K, Shukla P, Sickles A, Silva C, Silvermyr D, Singh B, Singh C, Singh V, Skolnik M, Slunečka M, Snowball M, Solano S, Soltz R, Sondheim W, Sorensen S, Sourikova I, Stankus P, Steinberg P, Stenlund E, Stepanov M, Ster A, Stoll S, Stone M, Sugitate T, Sukhanov A, Sumita T, Sun J, Sziklai J, Takahara A, Taketani A, Tanaka Y, Tanida K, Tannenbaum M, Tarafdar S, Taranenko A, Tennant E, Tieulent R, Timilsina A, Todoroki T, Tomášek M, Torii H, Towell C, Towell M, Towell R, Towell R, Tserruya I, van Hecke H, Vargyas M, Vazquez-Zambrano E, Veicht A, Velkovska J, Vértesi R, Virius M, Vrba V, Vznuzdaev E, Wang X, Watanabe D, Watanabe K, Watanabe Y, Watanabe Y, Wei F, Whitaker S, White A, Wolin S, Woody C, Wysocki M, Xia B, Xue L, Yalcin S, Yamaguchi Y, Yanovich A, Yokkaichi S, Yoo J, Yoon I, You Z, Younus I, Yu H, Yushmanov I, Zajc W, Zelenski A, Zhou S, Zou L. Inclusive cross section and double-helicity asymmetry forπ0production at midrapidity inp+pcollisions ats=510 GeV. Int J Clin Exp Med 2016. [DOI: 10.1103/physrevd.93.011501] [Citation(s) in RCA: 35] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
125
|
Murakami Y, Ikeda Y, Nakatake S, Miller JW, Vavvas DG, Sonoda KH, Ishibashi T. Necrotic cone photoreceptor cell death in retinitis pigmentosa. Cell Death Dis 2015; 6:e2038. [PMID: 26720347 PMCID: PMC4720913 DOI: 10.1038/cddis.2015.385] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
|